ProQR Therapeutics N.V. buy Chardan Capital
Start price
12.12.24
/
50%
€3.10
Target price
12.12.25
€3.81
Performance (%)
-37.48%
End price
13.12.25
€1.94
Summary
This prediction ended on 13.12.25 with a price of €1.94. The BUY prediction by Chardan_Capital for ProQR Therapeutics N.V. performed very badly with a performance of -37.48%. Chardan_Capital has a follow-up prediction for ProQR Therapeutics N.V. where he still thinks ProQR Therapeutics N.V. is a Buy. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| ProQR Therapeutics N.V. | -6.074% | -6.074% | -28.100% |
| iShares Core DAX® | 1.732% | 4.638% | 21.634% |
| iShares Nasdaq 100 | 3.304% | 0.517% | 5.422% |
| iShares Nikkei 225® | 2.342% | 0.972% | 15.333% |
| iShares S&P 500 | 2.357% | 0.872% | 3.125% |
Comments by Chardan_Capital for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $4.00 price target on the stock.
Ratings data for PRQR provided by MarketBeat
In the thread Trading ProQR Therapeutics N.V.
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten
Current prediction by Chardan_Capital for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.59
14.03.25
14.03.25
€3.69
14.03.26
14.03.26
17.38%
23.12.25
23.12.25
Stopped prediction by Chardan_Capital for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€2.05
04.11.25
04.11.25
€3.48
04.11.26
04.11.26
-13.83%
23.12.25
23.12.25
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.80
08.08.25
08.08.25
€3.43
08.08.26
08.08.26
4.06%
23.12.25
23.12.25
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.86
10.05.24
10.05.24
€2.32
10.05.25
10.05.25
-20.11%
11.05.25
11.05.25
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.27
08.11.23
08.11.23
€1.87
08.11.24
08.11.24
170.93%
09.11.24
09.11.24